U.S. Ibuprofen Prices 2025, Size, Trend, Graph, Chart and Forecast

The U.S. Ibuprofen market in Q4 2024 experienced notable volatility, beginning with a strong price surge but concluding with a substantial decline. October witnessed a sharp increase in prices, driven by seasonal demand from the food and beverage sector, escalating shipping costs from Asian suppliers, and supply chain disruptions exacerbated by an ILWU strike. Additionally, rising propionic acid prices and strategic stockpiling by traders anticipating winter demand contributed to further price inflation. Strong export demand and global supply uncertainties, particularly those linked to disruptions in Ukraine and the Middle East, added another layer of unpredictability to the market.

However, by December, market conditions shifted dramatically. A sharp decline in demand from key sectors, particularly pharmaceuticals, coupled with an oversupply stemming from high inventory levels, led to downward pressure on prices. Increased competition from Chinese imports, combined with destocking efforts by domestic suppliers and stable production rates, created an excess supply scenario that further depressed the market. Limited trading activity, reduced buyer enthusiasm, and high port inventories signaled a bearish outlook, marking a turbulent end to the quarter. These fluctuations underscored the market’s sensitivity to changing supply and demand conditions, highlighting significant price instability throughout Q4.

Get Real time Prices for Ibuprofen: https://www.chemanalyst.com/Pricing-data/ibuprofen-1331

In China, the ibuprofen market displayed a similarly dynamic pattern, with early price surges followed by stabilization and eventual declines as supply adjustments took effect. October saw a sharp rise in prices, fueled by supply shortages, logistical disruptions caused by severe typhoons, and robust pharmaceutical sector demand. Low inventories, increased procurement for winter and festive seasons, and rising raw material costs—especially for propionic acid—further supported price growth. However, by November, the market saw a modest correction as supply chains adapted, and destocking efforts eased previous price pressures. While export prices remained lower, steady demand created strategic buying opportunities. By December, several structural challenges, including high inventory levels, geopolitical uncertainties such as tariff threats, and concerns over Chinese currency manipulation, weakened the market. Increased destocking efforts and cautious buyer sentiment contributed to a buyer-favorable environment, keeping prices suppressed. Additionally, declining propionic acid costs due to stable production levels and moderate downstream demand further eased input costs, leading to an overall downward market correction after the initial spike in Q4.

The German ibuprofen market followed a distinctly bearish trajectory, with persistent price declines throughout Q4 2024. Surplus supply, combined with subdued demand, led to continuous downward price pressure. Weak industrial activity, excess inventories, and conservative procurement strategies contributed to this trend. Favorable production conditions and pre-holiday stockpiling resulted in an oversupply scenario, further exacerbating price declines. The contraction in Germany’s Manufacturing PMI to 42.5 in December signaled reduced industrial output and a drop in new orders, directly impacting ibuprofen sales. While lower input costs and improved lead times provided some relief, weak business confidence and economic uncertainties continued to suppress market recovery. In response, suppliers implemented aggressive pricing strategies, including discounts and inventory destocking, in an attempt to counter oversupply and maintain market presence. Despite these efforts, lackluster demand and cautious inventory management perpetuated a bearish outlook. Looking ahead, market stabilization will depend on an industrial recovery and an uptick in demand. To navigate these challenging conditions, industry players must optimize inventory management, strengthen buyer relationships, and closely monitor economic indicators to maintain resilience in an uncertain market environment.

Get Real time Prices for Ibuprofen: https://www.chemanalyst.com/Pricing-data/ibuprofen-1331

Our Blog: 

Non-Polar Solvents Prices: https://www.chemanalyst.com/Industry-data/non-polar-solvents-13

Pharmaceuticals Raw Materials Prices: https://www.chemanalyst.com/Industry-data/pharmaceuticals-raw-materials-14

Contact Us:

ChemAnalyst

GmbH – S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, Germany

Call: +49-221-6505-8833

Email: [email protected]

Website: https://www.chemanalyst.com